title: [An investigation of extracellular HER-2/NEU domain level in blood serum from breast cancer patients].
abstract: A series of 159 tests on HER2 ECD in blood serum from breast cancer patients established the following correlations: enhanced levels of the marker occurred more often in patients with multiple metastases to different organs alongside those with bone metastases; patients in loco-regional relapse tended to show elevated levels too. It is suggested that the method be used for prognosis and monitoring.
authors.forename: L I
authors.initials: LI
authors.lastname: Korytova
authors.forename: E A
authors.initials: EA
authors.lastname: Masliukova
authors.forename: I V
authors.initials: IV
authors.lastname: Ovchinnikov
authors.forename: M O
authors.initials: MO
authors.lastname: Filipenko
authors.forename: O V
authors.initials: OV
authors.lastname: Korytov
authors.forename: A G
authors.initials: AG
authors.lastname: Kudaĭbergenova
mesh_terms: D000328:Adult; D000368:Aged; D014408:Biomarkers, Tumor / Q000097:blood*; D001943:Breast Neoplasms / Q000097:blood* / Q000473:pathology*; D005260:Female; D006801:Humans; D008875:Middle Aged; D011237:Predictive Value of Tests; D011379:Prognosis; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000097:blood*; D044967:Serum / Q000378:metabolism*
chemical_list: D014408:Biomarkers, Tumor; D018719:Erb-b2 Receptor Tyrosine Kinases